Hinova plans to use the funding capital to support its multi-center clinical trials and the commercialization of the firm’s drug candidates in China and internationally.
Gaming hardware unicorn Razer begins operations of its Singapore-based face mask production facility. It plans to manufacture up to 5 million face masks per month to combat the COVID-19 pandemic.